Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart
about
Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptorTranscription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. [corrected]Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progressionTGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestineRepulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4Slug is a direct Notch target required for initiation of cardiac cushion cellularizationHemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogeninDual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2Genetic dissection and prognostic modeling of overt stroke in sickle cell anemiaDisruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchymeMEKK3 initiates transforming growth factor beta 2-dependent epithelial-to-mesenchymal transition during endocardial cushion morphogenesisIntegration of the Gene Ontology into an object-oriented architectureEpidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basisGenetics of valvular heart diseaseA role for smad6 in development and homeostasis of the cardiovascular systemReal-time monitoring of the interactions of transforming growth factor-beta (TGF-beta ) isoforms with latency-associated protein and the ectodomains of the TGF-beta type II and III receptors reveals different kinetic models and stoichiometries of biRecombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agentTransforming growth factor Beta2 is required for valve remodeling during heart developmentHeart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryosEssential role of Sox9 in the pathway that controls formation of cardiac valves and septaIdentification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signalingLigand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart developmentA murine model of hereditary hemorrhagic telangiectasiaEssential role for ADAM19 in cardiovascular morphogenesisModulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motilityThe chick embryo as an expanding experimental model for cancer and cardiovascular researchTranscriptional control by the TGF-beta/Smad signaling systemIdentification, cloning, and developmental expression of hepatoma-derived growth factor in the developing rat heart.Outflow tract cushions perform a critical valve-like function in the early embryonic heart requiring BMPRIA-mediated signaling in cardiac neural crestMatrix metalloproteinase 2-integrin alpha(v)beta3 binding is required for mesenchymal cell invasive activity but not epithelial locomotion: a computational time-lapse study.The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42.The type III transforming growth factor-β receptor inhibits proliferation, migration, and adhesion in human myeloma cells.The type III TGFβ receptor regulates filopodia formation via a Cdc42-mediated IRSp53-N-WASP interaction in epithelial cells.Matrix metalloproteinase inhibitors suppress transforming growth factor-beta-induced subcapsular cataract formation.On the role of shear stress in cardiogenesis.NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells.Type III transforming growth factor-beta (TGF-beta) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-beta signaling pathwayYap1 is required for endothelial to mesenchymal transition of the atrioventricular cushion.Roles for the type III TGF-beta receptor in human cancerLocalization of a novel melanoma susceptibility locus to 1p22
P2860
Q24290737-F82937FE-4192-448C-A88F-3CF78EAF4884Q24293493-A70F9349-D833-4E51-B532-7088544707F6Q24300340-82B119BD-B357-40BE-BB76-A4B8F35DE486Q24301263-AC7179C3-B119-49D5-945E-43C51B099A50Q24304414-103E47F7-5BD5-482D-A21A-0047F39BF67DQ24318449-6692A4DC-AEF0-4736-8015-EBD2929A6D0AQ24321923-CB87FE14-85B4-48C1-97BB-5CA8377CEF44Q24607154-A46B05BF-A802-407D-9326-75EFDCE8FE33Q24621301-C97089B2-2D57-4E1A-BCE5-9FFE2316AD9BQ24629543-E0EA42E6-BF4D-4249-AA02-528C1D909620Q24650601-CCDAA322-D256-4C5F-979B-E80B015E3D84Q24810653-37C2381C-1527-49CC-91E5-6ADF6AFC953AQ26828458-3A3EBDE3-5B54-4BB4-81B0-90AC60F93CABQ27014805-7464D327-853E-42ED-BB22-D79BE2EB57D9Q28143788-C4BD8EF4-32E7-49BC-855E-F82317C38A0DQ28198041-8D524759-E934-4361-8BBA-548DE10CC99BQ28360679-A3D42C8A-A51C-4F8F-A478-44F12364C159Q28505676-F8D483D8-D440-48C7-9198-629F2A9E9947Q28508310-C58556D2-F1BC-4F99-99C3-EBA5BD0DCBE8Q28509327-61C8D8C3-0F3C-4525-9735-4F65C31B36CFQ28575076-0DF49DA3-5610-463B-B023-20E7C7B62371Q28589791-9CC5DEAE-B0E8-4183-BD14-691A8D63F42BQ28592376-D6B4845A-DA49-4B2F-80E8-01086B8BDDB2Q28594617-BCAE6758-945C-4065-8CC0-9C083797CCBEQ28594979-B8BBAFAB-7CC7-4560-915E-E8748979D51FQ28655771-B227EB7E-B471-4C63-A1D7-A91AF824BF10Q29618985-2719286B-A971-4E17-B60A-65AED45F0AF1Q30308377-EC77C289-6767-4F51-9912-FD84DD98245FQ30478829-01E83464-1508-4EF9-8F45-BDF05C40218FQ30484821-102A7A87-727C-460B-93E0-991417A52216Q30487886-5F02CAA0-7020-4416-B556-EC6D6E89E74EQ30499958-7F4DFBAE-F155-4633-A9F3-96D0F73F6B49Q30582833-6865A452-84C6-4B04-9AE4-90CBD8BCD27AQ33231118-61AFFA82-1B86-4004-A865-0CFD3397D57CQ33231552-BFE0C190-8DB8-4583-96FF-53E86DA792BBQ33619019-478B5961-436A-48D5-9FAF-A8E04113CAC6Q33749558-6C492EB4-9966-4494-B0F2-49101F8903D1Q33846400-A925A196-BA7F-4C28-8AAE-579BB45D3448Q33872593-6B5EE32D-6F96-4A74-B1C3-BF8DAD693373Q33905176-D0FC531E-8B4A-4AF9-AC56-C26640DADD88
P2860
Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Requirement of type III TGF-be ...... ll transformation in the heart
@ast
Requirement of type III TGF-be ...... ll transformation in the heart
@en
Requirement of type III TGF-be ...... ll transformation in the heart
@en-gb
Requirement of type III TGF-be ...... ll transformation in the heart
@nl
type
label
Requirement of type III TGF-be ...... ll transformation in the heart
@ast
Requirement of type III TGF-be ...... ll transformation in the heart
@en
Requirement of type III TGF-be ...... ll transformation in the heart
@en-gb
Requirement of type III TGF-be ...... ll transformation in the heart
@nl
prefLabel
Requirement of type III TGF-be ...... ll transformation in the heart
@ast
Requirement of type III TGF-be ...... ll transformation in the heart
@en
Requirement of type III TGF-be ...... ll transformation in the heart
@en-gb
Requirement of type III TGF-be ...... ll transformation in the heart
@nl
P2093
P921
P3181
P1433
P1476
Requirement of type III TGF-be ...... ll transformation in the heart
@en
P2093
J V Barnett
R B Runyan
P304
P3181
P356
10.1126/SCIENCE.283.5410.2080
P407
P577
1999-03-26T00:00:00Z